Larimar Therapeutics (LRMR) Payables (2013 - 2026)
Larimar Therapeutics' Payables came in at $7.6 million for Q2 2026, up 82.2% from $4.17 million a year earlier.
Powered by 
Analysis
Larimar Therapeutics (LRMR) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Larimar Therapeutics' Payables was $5.22 million, up 115.2% from FY2024.
- Payables carries a five-year compound annual growth rate of 14.6% (FY2020 to FY2025).
- Going back by year, Payables was $2.42 million in FY2024 (+88.9%), $1.28 million in FY2023 (-23.9%), $1.69 million in FY2022 (+1.6%) and $1.66 million in FY2021 (-37.0%).
- The five-year range for quarterly Payables is $425,000 (Q2 2022) to $11.1 million (Q3 2025).
- The fastest year-over-year change in Payables over five years came in Q3 2025 (growth of 558.4%), and the weakest in Q1 2023 (a decline of 71.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Larimar Therapeutics | 252.95 Mn | -354.12 Mn | - | 7.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.60 Mn |
| Dec 31, 2025 | 5.22 Mn |
| Sep 30, 2025 | 11.10 Mn |
| Jun 30, 2025 | 4.17 Mn |
| Mar 31, 2025 | 2.27 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 2.92 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 756,000.00 |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 695,000.00 |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 849,000.00 |
| Jun 30, 2022 | 425,000.00 |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 1.77 Mn |
| Jun 30, 2021 | 1.46 Mn |
API Access
Larimar Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=LRMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "LRMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=LRMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();